AMYLIN PHARMACEUTICALS INC 4
4 · AMYLIN PHARMACEUTICALS INC · Filed Jul 6, 2006
Insider Transaction Report
Form 4
EBERHARD CRAIG A
VP Sales
Transactions
- Exercise/Conversion
Common Stock
2006-07-03$18.85/sh+1,500$28,275→ 23,293 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2006-07-03−1,500→ 15,800 totalExercise: $18.85From: 2003-05-12Exp: 2013-05-12→ Common Stock (1,500 underlying) - Sale
Common Stock
2006-07-03$48.01/sh−1,500$72,017→ 21,793 total
Footnotes (1)
- [F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.